Posted by: Epsilon
Five Star Quality Care Inc. (FVE) has a P/B of 0.52 with a ROE of 28.02%. The company holds an average analyst price target, from a total of three analysts, of $4.73, 54.57% above its current price of $3.06.
The stock has used the $3.00 price level as strong support throughout 2012. As it is now trading just above this level, at $3.06, investors may find opportunity in this entry point…
Read the full article at Continue Reading →
Posted by: Epsilon
As worries in Europe continue to push markets downward, many stocks are now selling at a relative discount. This two-part series will focus on stocks that appear undervalued due to low price-to-book ratios (P/B) and high, over 20%, return on equity (ROE).
A company’s price-to-book ratio and return on equity are generally good fundamental statistics to look at when beginning a search for value opportunities. A low P/B, a ratio used to compare a stock’s market value to its actual book ...
Continue Reading →Below is a list of five equities with significant upside, 35% average, that are trading just above strong support.
1. Communications Systems, Inc. (JCS), a communication equipment manufacturer, is currently trading at $12.88; just above support at $12.50. This stock has not spent more than a few sessions below this strong support level since October, 2010. Of notable fundamental statistics, Communications Systems, Inc. has a very low price to sales ratio (P/S) of 0.76, a strong return on equity ...
Continue Reading →As any investor will no doubt be aware, it is extremely important to keep track of your investments. Thankfully, there are a number of ways in which investors are able to do this. If you are keen to make the most of the investments which you have, then here are a few ways in which you might choose to keep track of them.
One of the best ways to keep track of the investments which you have is via ...
Continue Reading →A stock’s dividend yield is a good initial indicator of the kind of value you are getting when purchasing the stock. A higher dividend yield means a better value, generally.
As December approaches, the month believed to be the best time to buy and sell long term positions according to O’Shaughnessy’s cornerstone strategy, rebalancing my long term portfolio, is becoming a priority. In my search for long term opportunities, and with the sting of this year’s market turbulence not yet forgotten, ...
Continue Reading →Healthcare plans’ stocks were hit hard in August as budget talks instilled fear into already worried investors. By mid-month, however, many of the industry’s stocks began consolidating and finding strong levels of price support.
As we moved through September, analysts began taking notice of healthcare plans, using words like “oversold” and “undervalued” when describing the industry. As we are about to close the doors on September, many stocks in the industry have bounced off of price support and are continuing to ...
Continue Reading →With the recent market sell-off behind us investors are looking for hope, optimism, and opportunity. Last week Healthcare investors began to worry about possible spending cuts that may affect the sector. A recent Reuters article, however, brought reassurance to investors stating, “Sharp falls in U.S. Healthcare stocks this week — where industry bellwethers dropped as much as 8 percent in one day — were a premature sell-off, analysts say, as the sector’s underlying fundamentals remain strong.”… Continue Reading →
In a recent article written about healthcare stocks with significant upside potential, I offered a fundamental and technical breakdown of four healthcare stocks trading under $15.00. After noticing continued price performance after the publication of the article, and as three of the four stocks mentioned were biotechnology stocks, I began searching for additional opportunities in the biotechnology industry. As you may have guessed, it didn’t me take long to find what I was looking for…
Read full article Continue Reading →
